RSC Advances
Paper
4-methoxycarbonylphenylboronic acid pinacol ester (0.71 g,
2.7 mmol) in THF (17 mL), and the system was heated to reux
overnight. Aer an aqueous phase was extracted with ethyl
acetate, the combined organic phase was washed with brine.
Aer drying over MgSO4, solvents were removed by the
rotary evaporator. The resulting solid residue was puried by
recrystallization from DCM and hexane to yield yellow powder
(0.82 g, 82%).
Monomer synthesis
N-Octyl-4-iodoacetanilide (3). NaH (55% oil suspension)
(0.58 g, 14 mmol) was added to a solution of 4-iodoacetanilide
(3.2 g, 12 mmol) in DMF (60 mL) at 0 C, and stirred at room
ꢁ
temperature for 30 min. 1-Bromooctane (3.1 mL, 18 mmol) was
added to the solution and the system was heated to 100 ꢁC for 24
h. The reaction mixture was poured into water and an aqueous
phase was extracted with ethyl acetate. The combined extracts
were dried over MgSO4 and solvents were removed by the rotary
evaporator. The crude product was puried by SiO2 chroma-
tography (DCM then DCM–ethyl acetate ¼ 1/1) to obtain yellow
liquid (3.8 g, 85%). 1H NMR (d, 200 MHz, ppm, CDCl3) 7.75 (d,
J ¼ 7.9 Hz, 2H), 6.93 (d, J ¼ 7.9 Hz, 2H), 3.65 (t, J ¼ 7.4 Hz, 2H),
1.46 (m, 2H), 1.36–1.17 (10H), 0.87 (t, J ¼ 5.2 Hz, 3H). 13C NMR
(d, 50 MHz, ppm, CDCl3) 170.0, 142.9, 140.2, 137.5, 131.5, 129.0,
93.3, 49.0, 32.0, 29.3, 27.8, 22.8, 13.5. IR (cmꢀ1) 2923, 2854,
1658, 1581, 1484, 1400, 1288, 1058, 1008, 831, 717.
N-Octyl-4-(10-bromo-9-anthracenyl)acetanilide (4). 2 M aq.
K2CO3 (5.0 mL) and Pd(PPh3)4 (65 mg, 50 mmol) were added to a
mixture of 3 (0.65 g, 2.2 mmol) and 10-bromoanthracene-9-
boronic acid (1.0 g, 2.7 mmol) in THF (20 mL), and the system
was heated to reux overnight. Aer an aqueous phase was
extracted with ethyl acetate, the combined organic phase was
washed with brine. Aer drying over MgSO4, solvents were
removed by the rotary evaporator. The crude product was
puried by ash chromatography (acetone–hexane ¼ 3/5) to
obtain yellow powder (1.0 g, 92%).
M.p. 192–193 ꢁC. 1H NMR (d, 600 MHz, ppm, CDCl3) 8.28 (d,
J ¼ 8.4 Hz, 2H), 7.86 (m, 2H), 7.61–7.55 (4H), 7.32, (m, 4H), 7.26
(d, J ¼ 8.7 Hz, 2H), 6.82 (d, J ¼ 8.7 Hz, 2H), 3.82 (bs, 1H), 3.24 (t,
J ¼ 6.9 Hz, 2H), 1.72 (m, J ¼ 6.9 Hz, 2H) 1.48 (m, J ¼ 6.9 Hz, 2H),
1.42–1.27 (8H), 0.90 (t, J ¼ 6.8 Hz, 3H). 13C NMR (d, 150 MHz,
ppm, CDCl3) 167.1, 147.9, 144.6, 138.5, 135.1, 132.1, 131.6, 130.3,
129.7, 129.6, 129.3, 127.5, 126.9, 126.3, 125.3, 124.8, 112.4, 52.2,
44.2, 31.9, 29.7, 29.5, 29.2, 27.2, 22.7, 14.2. IR (cmꢀ1) 3400, 2923,
2853, 1707, 1606, 1521, 1478, 1433, 1391, 1319, 1271, 1176, 1111,
1020, 942, 818, 765, 709, 670, 609. Anal. calcd for C36H37NO2: C,
83.85; H, 7.23; N, 2.72. Found: C, 83.65; H, 7.30; N, 2.65%.
General procedure of cyclic oligomerization
Method A. A THF solution of 1 (0.2 M, 0.5 mL) was added
dropwise to a THF solution of LiHMDS (1.0 M in THF, 0.5 mL),
and the system was stirred for 6 h. Aer saturated NH4Cl was
added, an aqueous phase was extracted with DCM. A combined
organic phase was dried over MgSO4 and solvents were removed
by the rotary evaporator.
M.p. 135–136 ꢁC. 1H NMR (d, 200 MHz, ppm, CDCl3) 8.64 (d,
J ¼ 9.7 Hz, 2H), 7.68–7.55 (4H), 7.51–7.34 (6H), 3.83 (t, J ¼ 8.0
Hz, 2H), 2.03 (s, 3H), 1.73–1.60 (2H), 1.36–1.17 (10H), 0.88 (t, J ¼
6.6 Hz, 3H). 13C NMR (d, 50 MHz, ppm, CDCl3) 170.2, 142.8,
138.0, 136.3, 133.9, 131.0, 130.2, 129.4, 128.2, 127.2, 126.7,
Method B. A THF solution of LiHMDS (1.0 M in THF, 0.5 mL)
was added dropwise to a THF solution of 1 (0.1 M, 1.0 mL), and
the system was stirred for 6 h. Aer saturated aq. NH4Cl was
added, an aqueous phase was extracted with DCM. A combined
organic phase was dried over MgSO4 and solvents were removed
by the rotary evaporator. The crude product was puried by
preparative GPC (CHCl3 as an eluent) to obtain cyclic oligomers.
C3A. Yield, 40%. M.p. > 300 ꢁC. 1H NMR (d, 600 MHz, ppm,
CDCl3) 7.64 (d, J ¼ 8.0 Hz, 6H), 7.54 (d, J ¼ 8.9 Hz, 6H), 7.47
(d, J ¼ 8.9 Hz, 6H), 7.41 (d, J ¼ 8.2 Hz, 6H), 7.39–7.36 (12H), 6.94
(m, 6H), 6.89 (m, 6H), 4.21 (t, J ¼ 7.8 Hz, 6H), 1.91 (m, 6H), 1.54
(m, 6H), 1.38 (m, 6H), 1.36–1.30 (18H), 0.91 (t, J ¼ 6.8 Hz, 9H).
13C NMR (d, 150 MHz, ppm, CDCl3) 170.9, 143.5, 140.7, 137.9,
136.8, 136.6, 136.3, 132.4, 131.0, 130.0, 129.9, 129.4, 128.5,
126.9, 126.6, 126.0, 125.9, 50.5, 32.3, 29.9, 29.7, 28.5, 27.5, 23.1,
14.6. IR (cmꢀ1) 3904, 3059, 2925, 2852, 1648, 1603, 1511, 1438,
1377, 1293, 1177, 1020, 943, 828, 766, 670, 611. MALDI-TOF MS
calcd for C105H100N3O3 (M + H+): 1451.78. Found: 1451.73. Anal.
calcd for C105H99N3O3: C, 86.92; H, 6.88; N, 2.90. Found: C,
86.33; H, 6.93; N, 2.77%.
124.3, 123.3, 93.3, 49.0, 32.0, 29.3, 27.8, 22.8, 13.5. IR (cmꢀ1
2958, 2920, 2853, 1638, 1592, 1511, 1402, 1296, 1026, 936, 879,
765, 751, 620.
N-Octyl-4-(10-bromo-9-anthracenyl)aniline
eneglycol (2 mL) and conc. HCl (8 mL) were added to a solution
)
(5).
Ethyl-
of 4 (1.3 g/2.6 mmol) in DOX (6 mL), and the system was stirred
ꢁ
for 48 h at 100 C. The reaction mixture was neutralized using
saturated aq. Na2CO3, and an aqueous phase was extracted with
DCM. The combined organic phase was washed with brine.
Aer drying over MgSO4, solvents were removed by the rotary
evaporator. The crude product was puried by column chro-
matography (ethyl acetate–hexane ¼ 1/1) to obtain yellow
powder (0.85 g, 71%).
M.p. 85–86 ꢁC. 1H NMR (d, 200 MHz, ppm, CDCl3) 8.57 (d, J ¼
8.8 Hz, 2H), 7.80 (d, J ¼ 8.8 Hz, 2H), 7.55 (t, J ¼ 7.9 Hz, 2H), 7.34
(d, J ¼ 7.9 Hz, 2H), 7.12 (d, J ¼ 8.3 Hz, 2H), 6.77 (d, J ¼ 8.8 Hz,
2H), 3.79 (bs, 1H), 3.19 (t, J ¼ 6.7 Hz, 2H), 1.69 (m, 2H), 1.36–1.17
(10H), 0.90 (t, J ¼ 6.3 Hz, 3H). 13C NMR (d, 50 MHz, ppm, CDCl3)
147.9, 138.5, 133.1, 131.5, 130.2, 129.0, 128.2, 126.4, 125.4, 123.7,
122.0, 113.4, 44.1, 31.9, 29.6, 29.5, 29.4, 27.8, 22.8, 13.5. IR
(cmꢀ1) 3943, 3443, 2946, 2916, 2847, 1604, 1518, 1464, 1437,
1341, 1289, 1258, 1179, 1029, 933, 874, 813, 756, 722, 654, 611.
Monomer (1). 2 M aq. K2CO3 (6.8 mL) and Pd(PPh3)4 (52 mg,
40 mmol) were added to a mixture of 5 (0.78 g, 1.7 mmol) and
1
ꢁ
C4A. Yield 8%. M.p. > 300 C. H NMR (d, 600 MHz, ppm,
CDCl3) 7.67 (d, J ¼ 7.9 Hz, 6H), 7.60 (d, J ¼ 8.3 Hz, 6H), 7.57 (d,
J ¼ 8.3 Hz, 6H), 7.43 (d, J ¼ 8.3 Hz, 6H), 7.41 (d, J ¼ 8.3 Hz, 6H),
7.35 (d, J ¼ 8.3 Hz, 6H), 7.15 (t, J ¼ 7.0 Hz, 6H), 7.11 (t, J ¼ 7.0 Hz,
6H), 4.18 (t, J ¼ 7.4 Hz, 6H), 1.90 (m, 6H), 1.52 (m, 6H), 1.43 (m,
6H), 1.37 (m, 6H), 1.36–1.17 (18H), 0.90 (t, J ¼ 7.0 Hz, 9H). IR
(cmꢀ1) 3820, 3020, 2955, 2923, 2851, 1723, 1645, 1511, 1378,
1290, 1121, 1020, 764, 670, 612. MALDI-TOF MS calcd for
C
140H133N4O4 (M + H+): 1935.03. Found: 1934.50.
6758 | RSC Adv., 2014, 4, 6752–6760
This journal is © The Royal Society of Chemistry 2014